Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

TAYLOR PHILLIPPI

Allopathic & Osteopathic Physicians Family Medicine

NPI
1366070260
CMS profile
11458502
Location
FRANKLIN, LA

General Payments · PY2023–2025

$443.78

  • Reported across 23 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$265.16

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $265.16 14

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $85.53 4
Axsome Therapeutics, Inc. $57.20 3
Lilly USA, LLC $40.83 2
Novo Nordisk AS $29.71 2
ITI, Inc. $23.55 1
Exact Sciences Corporation $14.37 1
Acerta Pharma LLC $13.97 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $43.51 2
PY2024 $135.11 7
PY2025 $265.16 14

Payment records · PY2025 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2025 20232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $13.97 09/22/2025 Food and Beverage Undisputed 06/30/2026 1206700733 CMS
Axsome Therapeutics, Inc. $19.97 04/14/2025 Food and Beverage Undisputed 06/30/2026 1235628632 CMS
Axsome Therapeutics, Inc. $16.80 06/16/2025 Food and Beverage Undisputed 06/30/2026 1235739997 CMS
Axsome Therapeutics, Inc. $20.43 11/11/2025 Food and Beverage Undisputed 06/30/2026 1235582982 CMS
Exact Sciences Corporation $14.37 04/22/2025 Food and Beverage Undisputed 06/30/2026 1235275296 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.55 10/21/2025 Food and Beverage Undisputed 06/30/2026 1241381274 CMS
Lilly USA, LLC $18.38 04/08/2025 Food and Beverage Undisputed 06/30/2026 1186934718 CMS
Lilly USA, LLC $22.45 10/15/2025 Food and Beverage Undisputed 06/30/2026 1186853795 CMS
Novo Nordisk Inc $13.67 03/24/2025 Food and Beverage Undisputed 06/30/2026 1188803628 CMS
Novo Nordisk Inc $16.04 07/29/2025 Food and Beverage Undisputed 06/30/2026 1188143350 CMS
Otsuka America Pharmaceutical, Inc. $19.89 02/05/2025 Food and Beverage Undisputed 06/30/2026 1227452290 CMS
Otsuka America Pharmaceutical, Inc. $21.65 05/13/2025 Food and Beverage Undisputed 06/30/2026 1227452294 CMS
Otsuka America Pharmaceutical, Inc. $17.11 10/07/2025 Food and Beverage Undisputed 06/30/2026 1227452298 CMS
Otsuka America Pharmaceutical, Inc. $26.88 11/03/2025 Food and Beverage Undisputed 06/30/2026 1227452303 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.